Clinical Trial Update: HEARTS Trial for Thoracic Cancers [Phase 2]

View source ↗

Summary

HEARTS is a Phase 2 clinical trial targeting thoracic cancers, including non-small cell lung cancer, esophageal cancer, esophagogastric cancer, and thymic tumor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophagogastric Cancer
• Non-small Cell Lung Cancer
• Thymic Carcinoma
• Thymoma

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Non-Small Cell Lung Cancer (Stage III), Esophageal Cancer Stage I-III | Phase 2 | Status: RECRUITING